4RMED

4RMED LLC is a San Antonio-based biotechnology company focused on the clinical development and regulatory management of regenerative medicine and infectious disease therapies. Founded in 2016 by Dr. Mary Pat Moyer, the company operates as the clinical and regulatory arm for its affiliate, INCELL Corporation, and other collaborative entities. 4RMED specializes in overseeing human subjects research protocols, managing Investigational New Drug (IND) applications, and preparing regulatory documents for biological products, medical devices, and combination products. Its portfolio includes cell and tissue-based therapies for indications such as Amyotrophic Lateral Sclerosis (ALS), acute pneumonia, and chronic wound healing. The company leverages a collaborative model to accelerate the translation of innovative biomanufacturing research into clinical applications.